Shop / Longevity medicine

Longevity medicine

For the first time, drugs are being developed to extend canine healthspan itself.

Systems touched: Endocrine, cardiovascular, nervous and immune systems.

Longevity medicine for dogs

What this category actually does

This is the newest and least settled category on the site. Loyal's programmes target the growth-hormone/IGF-1 axis and metabolic ageing in senior and large-breed dogs and are moving through the FDA's conditional-approval pathway. The Dog Aging Project's TRIAD trial tests low-dose rapamycin in healthy middle-aged dogs under academic, placebo-controlled conditions. Supplements in this space sit on real ageing biology but carry far weaker evidence than the drug programmes. Nothing here should be started without your veterinarian.

Key benefits

  • 01

    Whole-organism, not single-organ

    These interventions aim at the ageing process, so benefits are expected across several systems at once.

  • 02

    Addresses the size-lifespan tradeoff

    Large and giant breeds age fastest, and IGF-1 biology is the leading explanation.

  • 03

    Real regulatory and trial scrutiny

    The leading candidates are being tested against placebo and reviewed by regulators, rare in pet products.

  • 04

    Access to trials

    Enrolment in academic studies can bring intensive monitoring at no cost.

5 products in longevity medicine

  • LOY-002 by Loyal, illustrative image

    LOY-002

    Loyal

    Daily drug candidate aimed at extending healthy lifespan in senior dogs.

    Received an FDA milestone for reasonable expectation of effectiveness, a first for a canine longevity drug.

    Availability
    In FDA conditional-approval pathway
    Cost
    Not yet on sale
    Visit Loyal
  • LOY-001 / LOY-003 by Loyal, illustrative image

    LOY-001 / LOY-003

    Loyal

    Programmes targeting the growth-hormone/IGF-1 axis in large and giant breeds.

    Aimed squarely at the size-lifespan tradeoff: big dogs age faster, and IGF-1 is a leading suspect.

    Availability
    In development
    Cost
    Not yet on sale
    Visit Loyal
  • TRIAD Rapamycin Trial by Dog Aging Project, illustrative image

    TRIAD Rapamycin Trial

    Dog Aging Project

    Placebo-controlled trial of low-dose rapamycin in healthy middle-aged dogs.

    A multi-site, double-masked academic trial, the closest thing to a canine geroscience gold standard.

    Availability
    Enrolling / trial-dependent
    Cost
    No cost to enrolled participants
    Visit Dog Aging Project
  • Leap Years by Animal Bioscience, illustrative image

    Leap Years

    Animal Bioscience

    Senior-dog supplement built on NAD+ and senescent-cell science.

    Commercialised out of academic ageing-biology work rather than the usual joint-and-coat formulary.

    Availability
    Shipping
    Cost
    Subscription
    Visit Animal Bioscience
  • Longevity+ for Dogs by Petlio, illustrative image

    Longevity+ for Dogs

    Petlio

    Daily longevity blend for adult and senior dogs.

    Stacks six actives drawn from human longevity research into one chew.

    Availability
    Shipping
    Cost
    From around $27
    Visit Petlio

Be ready the day these approve

Members hold a measured baseline, so eligibility and effect can actually be assessed.

Other categories